Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Source: Eur Respir J 2003; 22: 484-490 Year: 2003
Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum Source: Annual Congress 2004 - Role of infection in COPD Year: 2004
The effect of montelukast on eosinophil apoptosis: Induced sputum findings of patients with mild persistant asthma Source: Eur Respir J 2003; 22: Suppl. 45, 101s Year: 2003
Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model Source: ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017 Year: 2017
Single-dose desloratadine and montelukast and allergen-induced late airway responses Source: Eur Respir J 2009; 33: 1302-1308 Year: 2009
Mechanisms of noneosinophilic asthma Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007
Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006
Neutrophil activation in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 400s Year: 2003
Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005
Neutrophil elastase in severe COPD and asthma exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 36s Year: 2006
Assessment of airway neutrophil activation in adult non-eosinophilic asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013
Role of neutrophils in airway inflammation in children with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Source: Eur Respir J 2006; 27: 483-494 Year: 2006
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma Source: Eur Respir J 2005; 25: 41-46 Year: 2005
IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 104s Year: 2003
Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005